Literature DB >> 17359935

Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties.

Vuk Savković1, Helen Gantzer, Ulrich Reiser, Lena Selig, Sebastian Gaiser, Ulrich Sack, Günter Klöppel, Joachim Mössner, Volker Keim, Friedemann Horn, Hans Bödeker.   

Abstract

Clusterin is overexpressed in pancreas during the acute phase of pancreatitis. We intended to clarify the role of clusterin expression in stressed exocrine pancreas. We performed in vitro experiments in transfected AR4-2J cells with modified expression levels of clusterin and in vivo studies in clusterin-deficient mice. AR4-2J cells were exposed to agents mimicking cell-stress during pancreatitis (cerulein, hydrogen peroxide, staurosporine or lysophosphatidylcholine). Clusterin-overexpressing AR4-2J cells showed higher viability after cell stress and accordingly reduced rates of apoptosis and lessened caspase-3 activation. Blockage of endogenous clusterin expression reduced viability and enhanced apoptosis. Presence of clusterin reduced NF-kappaB activation and expression of the NF-kappaB target genes TNF-alpha and MOB-1 under cell stress. Clusterin-deficient mice showed a more severe course of acute experimental pancreatitis with enhanced rates of apoptosis and inflammatory cell infiltration. We concluded that clusterin was protective during inflammation of exocrine pancreas because of its anti-apoptotic and anti-inflammatory functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359935     DOI: 10.1016/j.bbrc.2007.02.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.

Authors:  Arturo Sala; Saverio Bettuzzi; Sabina Pucci; Olesya Chayka; Michael Dews; Andrei Thomas-Tikhonenko
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

2.  Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.

Authors:  Shinwu Jeong; Dolena R Ledee; Gabriel M Gordon; Tatsuo Itakura; Nitin Patel; Aaron Martin; M Elizabeth Fini
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

3.  Identification of clusterin domain involved in NF-kappaB pathway regulation.

Authors:  Abdellatif Essabbani; Florence Margottin-Goguet; Gilles Chiocchia
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

4.  Enhancing or inhibiting apoptosis? The effects of ucMSC-Ex in the treatment of different degrees of traumatic pancreatitis.

Authors:  Zhao Zhirong; Han Li; He Yiqun; He Chunyang; Zhou Lichen; Tan Zhen; Wang Tao; Dai Ruiwu
Journal:  Apoptosis       Date:  2022-05-25       Impact factor: 5.561

5.  Clusterin exacerbates interleukin-1β-induced inflammation via suppressing PI3K/Akt pathway in human fibroblast-like synoviocytes of knee osteoarthritis.

Authors:  Tachatra Ungsudechachai; Sittisak Honsawek; Jiraphun Jittikoon; Wanvisa Udomsinprasert
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

6.  Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs.

Authors:  Matthew R Richardson; Xianyin Lai; Joseph L Dixon; Michael Sturek; Frank A Witzmann
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

7.  Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.

Authors:  Amina Zoubeidi; Susan Ettinger; Eliana Beraldi; Boris Hadaschik; Anousheh Zardan; Leo W J Klomp; Colleen C Nelson; Paul S Rennie; Martin E Gleave
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

8.  Association between clusterin concentration and dementia: a systematic review and meta-analysis.

Authors:  Caiping Yang; Hai Wang; Chaojiu Li; Huiyan Niu; Shunkui Luo; Xingzhi Guo
Journal:  Metab Brain Dis       Date:  2018-10-05       Impact factor: 3.584

9.  Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.

Authors:  Miao Xu; Xiumei Chen; Yanling Han; Chunqing Ma; Lin Ma; Shirong Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

10.  Clusterin confers gemcitabine resistance in pancreatic cancer.

Authors:  Qingfeng Chen; Zhengkun Wang; Kejun Zhang; Xiaoyi Liu; Weihong Cao; Lei Zhang; Shuhua Zhang; Bomin Yan; Yaoguang Wang; Chunping Xia
Journal:  World J Surg Oncol       Date:  2011-05-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.